The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.
News
UC San Diego Ranked Nation’s No. 6 Best Public University by U.S. News and World Report
UC San Diego has been ranked sixth among the nation’s top public colleges, according to U.S. News and World Report’s 2022 Best Global Universities. Released Tuesday, the publication ranked UC San Diego as the No… […]
News
Physicists Simulate Artificial Brain Networks with New Quantum Materials
As bandwidth demands on today’s computers reach their limit, scientists are developing systems with new materials that can match the speed and precision of animal nervous systems. UC San Diego physicists have no… […]
